Search Results

There are 40430 results for: content related to: Phase 1 trial of lipoplatin and gemcitabine as a second-line chemotherapy in patients with nonsmall cell lung carcinoma

  1. Intravesical gemcitabine for non-muscle invasive bladder cancer

    Intervention Review

    The Cochrane Library

    Gabriel Jones, Anne Cleves, Timothy J Wilt, Malcolm Mason, Howard G Kynaston and Mike Shelley

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD009294.pub2

  2. You have free access to this content
    Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review

    BJU International

    Volume 109, Issue 4, February 2012, Pages: 496–505, Mike D. Shelley, Gabriel Jones, Anne Cleves, Timothy J. Wilt, Malcolm D. Mason and Howard G. Kynaston

    Version of Record online : 7 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10880.x

  3. You have free access to this content
    Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells

    The FEBS Journal

    Volume 279, Issue 7, April 2012, Pages: 1261–1273, Fu Li, Gang Hu, Zhenzhou Jiang, Jingjing Guo, Ke Wang, Kedong Ouyang, Danyi Wen, Minghua Zhu, Jiaxin Liang, Xiaoran Qin and Luyong Zhang

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1742-4658.2012.08521.x

  4. You have full text access to this OnlineOpen article
    Gemcitabine-(5′-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)

    Chemical Biology & Drug Design

    Cody P. Coyne and Lakshmi Narayanan

    Version of Record online : 20 DEC 2016, DOI: 10.1111/cbdd.12845

  5. Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 2, March/April 2006, Pages: 507–514, C.J. POOLE, T. PERREN, S. GAWANDE, M. RIDDERHEIM, J. COOK, A. JENKINS and D. ROYCHOWDHURY

    Version of Record online : 25 APR 2006, DOI: 10.1111/j.1525-1438.2006.00466.x

  6. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

    Intervention Review

    The Cochrane Library

    Mike Shelley, Anne Cleves, Timothy J Wilt and Malcolm Mason

    Published Online : 13 APR 2011, DOI: 10.1002/14651858.CD008976.pub2

  7. You have full text access to this Open Access content
    RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells

    Journal of Cellular and Molecular Medicine

    Volume 12, Issue 6a, December 2008, Pages: 2334–2349, C. Yu, X. Zhang, G. Sun, X. Guo, H. Li, Y. You, J. L. Jacobs, K. Gardner, D. Yuan, Z. Xu, Q. Du, C. Dai, Z. Qian, K. Jiang, Y. Zhu, Q. Q. Li and Y. Miao

    Version of Record online : 6 FEB 2008, DOI: 10.1111/j.1582-4934.2008.00257.x

  8. You have free access to this content
    Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells

    FEBS Letters

    Volume 579, Issue 29, December 05, 2005, Pages: 6681–6687, Fuminori Teraishi, Lidong Zhang, Wei Guo, Fengqin Dong, John J. Davis, Anning Lin and Bingliang Fang

    Version of Record online : 14 NOV 2005, DOI: 10.1016/j.febslet.2005.10.064

  9. You have free access to this content
    Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma

    BJU International

    Volume 108, Issue 2, July 2011, Pages: 168–179, Michael D. Shelley, Anne Cleves, Timothy J. Wilt and Malcolm D. Mason

    Version of Record online : 1 JUL 2011, DOI: 10.1111/j.1464-410X.2011.10341.x

  10. You have free access to this content
    Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer

    British Journal of Pharmacology

    Volume 160, Issue 4, June 2010, Pages: 998–1007, Gabriela B Iwanski, Dhong H Lee, Shlomit En-Gal, Ngan B Doan, Brandon Castor, Marco Vogt, Melvin Toh, Carsten Bokemeyer, Jonathan W Said, Nils H Thoennissen and H Phillip Koeffler

    Version of Record online : 11 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00741.x

  11. You have full text access to this OnlineOpen article
    Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review

    Cancer Medicine

    Volume 3, Issue 6, December 2014, Pages: 1502–1511, Frédéric Fiteni, Thierry Nguyen, Dewi Vernerey, Marie-Justine Paillard, Stefano Kim, Martin Demarchi, Francine Fein, Christophe Borg, Franck Bonnetain and Xavier Pivot

    Version of Record online : 11 AUG 2014, DOI: 10.1002/cam4.299

  12. You have free access to this content
    Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin

    BJU International

    Volume 103, Issue 3, February 2009, Pages: 384–390, Mototsugu Muramaki, Alan So, Norihiro Hayashi, Richard Sowery, Hideaki Miyake, Masato Fujisawa and Martin E. Gleave

    Version of Record online : 24 OCT 2008, DOI: 10.1111/j.1464-410X.2008.08098.x

  13. You have free access to this content
    Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis

    British Journal of Clinical Pharmacology

    Volume 76, Issue 3, September 2013, Pages: 338–347, Wei-Xiang Qi, Feng Lin, Yuan-Jue Sun, Li-Na Tang, Zan Shen and Yang Yao

    Version of Record online : 20 AUG 2013, DOI: 10.1111/bcp.12203

  14. Synthesis and characterization of saccharide-functionalized polymer–gemcitabine conjugates based on chemoenzymatic selective strategy

    Journal of Applied Polymer Science

    Volume 124, Issue 3, 5 May 2012, Pages: 1840–1847, Guo-Jun Zhou, Xia Li, Ming-Xing Teng, Guo-Hai Chu and Xian-Fu Lin

    Version of Record online : 21 OCT 2011, DOI: 10.1002/app.35201

  15. You have free access to this content
    Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer

    Cancer

    Volume 118, Issue 4, 15 February 2012, Pages: 1119–1129, James D. Murphy, Daniel T. Chang, Jon Abelson, Megan E. Daly, Heidi N. Yeung, Lorene M. Nelson and Albert C. Koong

    Version of Record online : 19 JUL 2011, DOI: 10.1002/cncr.26365

  16. You have free access to this content
    Chemotherapy for advanced non-small cell lung cancer in the elderly population

    Intervention Review

    The Cochrane Library

    Fábio N Santos, Tiago B de Castria, Marcelo RS Cruz and Rachel Riera

    Published Online : 20 OCT 2015, DOI: 10.1002/14651858.CD010463.pub2

  17. Validation of a hydrophilic interaction ultra-performance liquid chromatography–tandem mass spectrometry method for the determination of gemcitabine in human plasma with tetrahydrouridine

    Biomedical Chromatography

    Volume 29, Issue 9, September 2015, Pages: 1343–1349, Yuji Mano, Kenji Sakamaki, Takuya Ueno, Kenji Kita, Takuho Ishii, Koichiro Hotta and Kazutomi Kusano

    Version of Record online : 2 FEB 2015, DOI: 10.1002/bmc.3429

  18. You have free access to this content
    Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing

    Immunology

    Volume 141, Issue 2, February 2014, Pages: 242–255, Liboria Siena, Elisabetta Pace, Maria Ferraro, Caterina Di Sano, Mario Melis, Mirella Profita, Mario Spatafora and Mark Gjomarkaj

    Version of Record online : 9 JAN 2014, DOI: 10.1111/imm.12190

  19. You have free access to this content
    Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate

    British Journal of Clinical Pharmacology

    Volume 65, Issue 3, March 2008, Pages: 326–333, Xuemin Jiang, Peter Galettis, Matthew Links, Paul L. Mitchell and Andrew J. McLachlan

    Version of Record online : 24 OCT 2007, DOI: 10.1111/j.1365-2125.2007.03040.x

  20. Labeling, biodistribution and evaluation of [125I] gemcitabine: a potential agent for tumor diagnosis and radiotherapy

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 52, Issue 3, March 2009, Pages: 91–97, O. A. El-Kawy, A. M. Hashem, M. A. Amin and A. S. El-Wetery

    Version of Record online : 16 JAN 2009, DOI: 10.1002/jlcr.1573